William Mcguire - Virginia Commonwealth University

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Final Survival Follow-Up and Translational Associations Using Interval Indirect Immunization with Oregovomab (O) and Poly ICLC in Patients (pts) with Recurrent Platinum-Resistant Ovarian Cancer (PROC)

Robert W. Holloway,Sarah Madhu Temkin,Sarah W. Gordon,Sunil Gupta,Christopher F. Nicodemus,Madi Madiyalakan,William P. McGuire

Journal of clinical oncology（2021）

引用0浏览0引用

A Randomized Phase II Evaluation of Weekly Gemcitabine Plus Pazopanib Versus Weekly Gemcitabine Alone in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma

L. R. Duska,G. R. Petroni, N. Varhegyi,J. Brown,D. Jelovac,K. N. Moore,W. P. McGuire,C. Darus,L. M. Barroilhet,A. A. Secord

Gynecologic oncologyno. 3 (2020): 585-592

引用9浏览0WOS引用

A Phase II Evaluation of Selumetinib (AZD6244, ARRY-142886), a Selective MEK-1/2 Inhibitor in the Treatment of Recurrent or Persistent Endometrial Cancer: an NRG Oncology/Gynecologic Oncology Group Study

Robert L Coleman,Michael W Sill,Premal H Thaker,David P Bender, Daron Street,William P McGuire,Carolyn M Johnston,Jacob Rotmensch

Gynecologic oncologyno. 1 (2015): 30-5

引用71浏览0WOS引用

Randomized Phase II Trial of Pegylated Liposomal Doxorubicin (PLD) with or Without Anti-Platelet-derived Growth Factor Receptor-Alpha (Pdgfr-Alpha) Monoclonal Antibody IMC-3G3 in Platinum-Refractory/resistant Advanced Ovarian Cancer

W. P. McGuire,G. D. Shah,N. Loizos,H. Youssoufian,E. K. Rowinsky,M. E. Gore

Journal of clinical oncology（2010）

引用2浏览0引用

Prospective Evaluation of Front-Line Chemo-Immunotherapy (C-It) with Oregovomab (2 Alternative Dosing Schedules) Carboplatinpaclitaxel (C-P) in Advanced Ovarian Cancer (Oc)

P. Braly, C. Chu, Y. Collins,R. Edwards,A. Gordon,W. McGuire, L. M. Smith,C. Nicodemus,M. Method

Journal of clinical oncology（2007）

引用4浏览0引用

Evaluation of Cyp3a Activity As A Predictive Covariate for Docetaxel Clearance

SD Baker,AJ Ten Tije,MA Carducci,H Gelderblom,FW Dawkins,WP McGuire,J Verweij

JOURNAL OF CLINICAL ONCOLOGY（2004）

引用8浏览0引用

Factors Affecting Cytochrome P-450 3a Activity In Cancer Patients

Sharyn D Baker,Ron H N van Schaik,Laurent P Rivory,Albert J Ten Tije,Kimberly Dinh,Wilfried J Graveland,Paul W Schenk,Kellie A Charles,Stephen J Clarke,Michael A Carducci,William P McGuire,Fitzroy W Dawkins,Hans Gelderblom,Jaap Verweij,Alex Sparreboom

CLINICAL CANCER RESEARCH（2004）

引用138浏览0WOS引用

138

Primary Ovarian Cancer Chemotherapy: Current Standards of Care

W P McGuire III,M Markman

British journal of cancerno. S3 (2003): S3-S8

引用151浏览0WOS引用

151

Progress in the Management of Gynecologic Cancer: Consensus Summary Statement

Stephen A Cannistra,Robert C Bast,Jonathan S Berek,Michael A Bookman, Christopher P Crum, Paul D DePriest,Judy E Garber, Wui-Jin Koh,Maurie Markman,William P McGuire,Peter G Rose, Eric K Rowinsky,Gordon J S Rustin,Steven J Skates,Paul A Vasey, Laura King

Journal of clinical oncology official journal of the American Society of Clinical Oncology（2003）

引用4浏览0WOS引用

The Story Of Taxol - Nature And Politics In The Pursuit Of An Anti-Cancer Drug

W. P. McGuire

SCIENCE（2001）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn